Helper T cells in antibody-mediated, organ-specific autoimmunity (Q33335330)

25 July 2017

1 reference

title

Helper T cells in antibody-mediated, organ-specific autoimmunity (English)

1 reference

25 July 2017

1 reference

Elson CJ

1 reference

25 July 2017

Barker RN

series ordinal

1 reference

25 July 2017

publication date

1 December 2000

1 reference

Current Opinion in Immunology

25 July 2017

published in

1 reference

25 July 2017

1 reference

25 July 2017

1 reference

25 July 2017

page(s)

664-669

1 reference

Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Identification of autoantigens in autoimmune haemolytic anaemia by a non-radioisotope immunoprecipitation method

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Multiple self epitopes on the Rhesus polypeptides stimulate immunologically ignorant human T cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Reduced frequency of HLA-DQ6 in individuals with a positive direct antiglobulin test

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Autoimmune hemolytic anemia and HLA-DQ6

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Enhanced IL-10 production in vitro by monocytes in autoimmune haemolytic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Involvement of IL-10 in induction of autoimmune hemolytic anemia in anti-erythrocyte Ig transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Involvement of CD4+ cells in lymphocytic choriomeningitis virus-induced autoimmune anaemia and hypergammaglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Proliferative responses of peripheral blood mononuclear cells from normal dogs and dogs with autoimmune haemolytic anaemia to red blood cell antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Autoreactive T cell specificity in autoimmune hemolytic anemia of the NZB mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Diverse antigen specificity of erythrocyte-reactive monoclonal autoantibodies from NZB mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Splenic but not thymic autoreactive T cells from New Zealand Black mice respond to a dominant erythrocyte Band 3 peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

High pathogenic potential of low-affinity autoantibodies in experimental autoimmune hemolytic anemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW x BXSB)F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Early-onset myasthenia gravis: a recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Interferon γ (IFN-γ) Is Necessary for the Genesis of Acetylcholine Receptor–induced Clinical Experimental Autoimmune Myasthenia gravis in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Heterogeneity of organ-specific autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Balance of Th1/Th2 cytokines in thyroid autoantibody synthesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Diverse patterns of unresponsiveness in an acetylcholine receptor-specific T-cell clone from a myasthenia gravis patient after engaging the T-cell receptor with three different ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Evaluating the Role of Th0 and Th1 Clones in Autoimmune Thyroid Disease by Use of Hu-SCID Chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Analysis of T cell responses to the autoantigen in Goodpasture's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Direct identification of naturally processed autoantigen-derived peptides bound to HLA-DR15.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Properties of HLA class II molecules divergently associated with Goodpasture's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Experimental autoimmune glomerulonephritis (EAG) induced by homologous and heterologous glomerular basement membrane in two substrains of Wistar-Kyoto rat

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with α3 chain of type IV collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900160-6

7 January 2021

10.1016/S0952-7915(00)00160-6

Identifiers

DOI

1 reference

25 July 2017

1 reference